BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Ciprofibrate, rs2230926, PDX1, Fatty acid metabolic process, Lung cancer, Leukocyte)
Bookmark Forward

QuickView for TRAIL binding (biogroup)


Body Atlas

Most Correlated Tissues

  1. Lung
  2. Fetal brain
  3. Medulla oblongata
  4. Occipital lobe
  5. Vestibular nuclei superior
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Lyme disease
  2. Antiphospholipid syndrome
  3. Disorder of pregnancy
  4. Multiple-resistant Staphylococcus aureus infection
  5. Acne
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. PHA 739358
  2. CEP 14083
  3. Ornithogalum glycoside
  4. DNA, Double-Stranded
  5. senkirkine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. ASF1B
  2. ZCCHC4
  3. RPS15A
  4. IRF5
  5. COL3A1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. A2780 and MCF7 cancer cell lines treated with CDK, HSP90, and topoisomerase inhibitors
  2. Cardiomyocytes and IPSCs with siRNA-mediated RPL39 or RPS15A knockdown
  3. Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals
  4. Embryonic stem WA09 cells response to DNA damage or differentiation
  5. Adult B-Acute Lymphoblastic Leukemia subtype mRNA profiling
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.
  2. Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.
  3. TRAIL therapy and prospective developments for cancer treatment.
  4. Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer …
  5. Combinatorial Screening of Peptides, Specific Ligands of Death Receptor DR5.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleura…
  2. Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malig…
  3. Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascite…
  4. A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment …
  5. Use of Tranexamic Acid After Vaginal Delivery With Episiotomy a RCT Placebo Control Trail
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.